Latest Stories
HHS Seeks Compliance Data From Hospitals in Drug-Discount Plan
The Health Resources and Services Administration sent letters to several hospitals that participate in a federal drug discount program earlier this month, asking the hospitals to provide detailed information about how they comply with the program’s requirements.
HHS, DOL Formalize Joint Effort to Combat Child Labor Violations
HHS, DOL Formalize Anti-Child Labor Exploitation Partnership
GOP Tees Up Prescription Drug, Fentanyl Bills for House Vote
A House committee advanced a Republican bill banning certain methods for measuring the effectiveness of prescription drugs, a move backed by major disability rights groups but opposed by the pharmaceutical industry’s biggest critics.
Target Lidocaine ‘Maximum Strength’ False-Ad Suit Moves Forward
Another “maximum strength” pain relief deception suit has advanced, as a federal judge said
AbbVie, Merz’s $54.4 Million Settlement in Namenda Suit Approved
AbbVie Inc. and Merz Holding Gmbh & Co. affiliates received final approval for a $54.4 million settlement of a lawsuit that claimed the pharmaceutical companies conspired to block generic competition for the Alzheimer’s drug Namenda.
Featured Topics
drug pricing
HHS Seeks Compliance Data From Hospitals in Drug-Discount Plan
GOP Tees Up Prescription Drug, Fentanyl Bills for House Vote
HHS, Agencies Sued Over Drug Price Transparency Rule Deferral
medical research
Cancer Drugs Should Use Gold Standard Trials in Fast Approvals
NIH Decision on Licensing of Cancer Drug Xtandi Appealed
Where Are We in Hunting for the Origin of Covid-19?: QuickTake
pharmaceuticals
HHS Seeks Compliance Data From Hospitals in Drug-Discount Plan
GOP Tees Up Prescription Drug, Fentanyl Bills for House Vote
Target Lidocaine ‘Maximum Strength’ False-Ad Suit Moves Forward
Other Topics
Covid-19 Vaccine: Can Your Employer Make You Take It?
Up Next
